Why the study?
Does inpatient left atrial appendage occlusion within 90 days affect all-cause readmission during days 91-270 in adults ≥65 years with nonvalvular atrial fibrillation and a bleeding or anticoagulation-alternative indication?
Does inpatient left atrial appendage occlusion within 90 days affect all-cause readmission during days 91-270 in adults ≥65 years with nonvalvular atrial fibrillation and a bleeding or anticoagulation-alternative indication?
In older adults with atrial fibrillation and a bleeding or anticoagulation-alternative indication alive at 90 days, inpatient LAAO was associated with higher subsequent all-cause, cardiovascular, and bleeding readmissions during days 91-270, though uncaptured out-of-hospital competing mortality and residual confounding may influence these findings.
Answers are grounded in this paper and cite their sources.
Higher readmission risk after LAAO in older adults with AF warrants caution in selection; observational data leave open confounding and require randomized confirmation.
Left atrial appendage occlusion (LAAO) is increasingly used in older adults with atrial fibrillation (AF) at risk of bleeding or contraindication to long-term anticoagulation, but its association with age and frailty is poorly described. Adults ≥65 years with nonvalvular AF at elevated thromboembolic risk whose index admission carried a coded bleeding event or an anticoagulation-alternative indication were identified in the Nationwide Readmissions Database (2018-2020). Patients alive at the 90-day landmark were stratified by LAAO vs. no LAAO within 90 days. The primary outcome was all-cause readmission during days 91-270. Survey-weighted logistic regression and propensity-score matching were used to estimate odds ratios (ORs) with 95% confidence intervals (CIs). Among 1,244,671 patients, 2070 underwent LAAO at a mean of 52.4 ± 23.4 days after index. LAAO was associated with higher adjusted odds of all-cause readmission (aOR 1.31, 95% CI 1.15-1.49) and cardiovascular readmission (aOR 1.33, 1.14-1.55). Bleeding readmission was also higher. In-hospital death at readmission did not differ. Age-by-frailty-by-LAAO interaction was not significant (p = 0.85), although subgroup analyses were underpowered. In older adults with AF and a bleeding event or an anticoagulation-alternative indication who were alive at 90 days, inpatient LAAO was associated with higher subsequent readmissions, including bleeding. Out-of-hospital deaths were not captured, and death competes with readmission, so higher readmission does not mean a worse net clinical outcome. These associations may reflect differences in baseline bleeding risk, inpatient exposure capture, and residual confounding.
No takes yet. Share an insight, caveat, or question.
Hazique et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: